http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101438542-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
| filingDate | 2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101438542-B1 |
| titleOfInvention | Immunologic adjuvant using ORF3 encoded by PCV2 |
| abstract | The present invention relates to a recombinant expression vector having a cleavage map of FIG. 1 into which a porcine circovirus 2 (PCV2) ORF3 gene has been introduced, and a immunoconjugate containing the recombinant expression vector. According to the present invention, overexpression of PCV2 ORF3 protein can induce overexpression of IL-6 and IL-8, which are inflammatory cytokines in the cell, resulting in a stronger immune response. Therefore, it is possible to prevent the infectious disease or cancer including PCW2- Can be usefully used for treatment or prevention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190135297-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190135296-A |
| priorityDate | 2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 335.